MARKET

DRRX

DRRX

DURECT
NASDAQ
0.7400
-0.0370
-4.76%
Opening 12:22 12/10 EST
OPEN
0.8000
PREV CLOSE
0.7770
HIGH
0.8195
LOW
0.7400
VOLUME
144.31K
TURNOVER
--
52 WEEK HIGH
1.880
52 WEEK LOW
0.4810
MARKET CAP
22.97M
P/E (TTM)
-1.3319
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DRRX last week (1202-1206)?
Weekly Report · 1d ago
Weekly Report: what happened at DRRX last week (1125-1129)?
Weekly Report · 12/02 12:23
Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
NASDAQ · 11/28 14:40
Oppenheimer Remains a Buy on Durect (DRRX)
TipRanks · 11/26 12:46
Durect (DRRX) Gets a Buy from Northland Securities
TipRanks · 11/25 14:55
BUZZ-U.S. STOCKS ON THE MOVE-Replimune, Snowflake, Virpax Pharmaceuticals
Reuters · 11/25 14:20
BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, GE Vernova, EQT Corp
Reuters · 11/25 12:20
Weekly Report: what happened at DRRX last week (1118-1122)?
Weekly Report · 11/25 12:11
More
About DRRX
DURECT Corporation is a late-stage biopharmaceutical company. The Company is engaged in the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Its lead drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in alcoholic hepatitis (AH) patients. Larsucosterol is in clinical development for the potential treatment of AH, for which the FDA has granted a Fast Track and a Therapy designation, and metabolic dysfunction-associated steatohepatitis (MASH) is also being explored. Its commercial pharmaceutical product includes POSIMIR (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the SABER platform technology. It has also completed Alcohol-Associated Hepatitis (AHFIRM) Phase 2b study.

Webull offers DURECT Corp stock information, including NASDAQ: DRRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DRRX stock methods without spending real money on the virtual paper trading platform.